| Net sales | Operating profit | Profit attributable to owners of parent | |||
| 140,000 | millions of yen | 8,500 | millions of yen | 2,800 | millions of yen |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
| Net sales | 123,649 | 124,314 | 136,030 | 132,885 | 137,117 |
| Operating profit | 4,673 | 4,880 | 5,812 | 6,777 | 7,921 |
| Profit attributable to owners of parent | 2,147 | 2,939 | 4,501 | 5,109 | 6,279 |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
| Net assets | 159,629 | 158,216 | 165,927 | 161,971 | 159,677 |
| Shareholders' Equity | 113,554 | 112,903 | 115,757 | 118,642 | 119,074 |
| Interest-bearing debt | 17,613 | 11,029 | 15,426 | 9,004 | 8,960 |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
| Cash flows from operating activities | 8,595 | 9,155 | 1,794 | 10,409 | 11,572 |
| Cash flows from investing activities | 1,169 | 6,806 | -5,920 | -190 | -7,485 |
| Free cash flows | 9,764 | 15,961 | -4,126 | 10,219 | 4,087 |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
| ROE | 1.9 | 2.6 | 3.9 | 4.4 | 5.3 |
| ROA | 3.1 | 3.4 | 3.7 | 4.1 | 5.1 |
| Operating profit ratio | 3.8 | 3.9 | 4.3 | 5.1 | 5.8 |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
| EPS | 120.94 | 168.93 | 261.38 | 150.55 | 189.70 |
| BPS | 6,419.62 | 6,535.42 | 6,789.78 | 3,556.36 | 3,667.20 |
| Dividend | 115.0 | 140.0 | 147.0 | 153.0 | 390.0 |
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
| Net sales | |||||
| Functional Solutions | 49,673 | 56,138 | 49,555 | 48,975 | 52,204 |
| Medical | - | - | 10,957 | 11,697 | 12,949 |
| Apparel | 62,640 | 57,197 | 60,986 | 60,114 | 60,782 |
| Lifestyle Creations | 11,976 | 11,576 | 15,327 | 12,826 | 12,005 |
| Operating profit | |||||
| Functional Solutions | 4,852 | 8,032 | 6,835 | 6,028 | 7,205 |
| Medical | - | - | 2,082 | 1,991 | 2,430 |
| Apparel | 2,306 | -557 | -222 | 1,465 | 753 |
| Lifestyle Creations | 482 | 453 | 705 | 833 | 988 |